25m
Hosted on MSNDrugs approved for other diseases may unlock a faster path to Alzheimer’s treatment, UNLV researcher saysDoctor Jeffrey Cummings is world-renowned in the field of Alzheimer's research and he leads UNLV's Center for Transformative Neuroscience.
Alzheimer’s disease and other types of dementia are becoming more common, and early detection can help people get treatment ...
Despite familiarity with cognitive screening and its benefits, current and emerging screening and testing tools for Alzheimer’s disease and related dementias remain vastly underused, according to ...
It could be as simple as constantly misplacing keys, or forgetting to pay a bill, or repeating questions over and over.
There is an inverse bidirectional association between cancer and dementia, a relationship that holds across cancer and dementia subtypes.
Chances are, you know someone with Alzheimer's disease or a related dementia involving memory loss. That's due in part to the fact that as our older population grows, so does the number of people ...
For the first time, researchers in Sweden have discovered a connection between rheumatoid arthritis (RA) and cognitive ...
Despite the potential benefits of early detection and increasing treatment options for Alzheimer's disease and related ...
Two widely touted Alzheimer’s drugs have been shown to enable patients to remain in their homes for longer periods of time.
Explore AC Immune's innovative Alzheimer's and Parkinson's therapies, key pharma collaborations, and financial outlook. Learn more on ACIU stock here.
Alzheimer's patients with a baseline CDR-SB score of 3.5 could expect approximately 4 additional months (95% CI 2-7 months) ...
After meeting with CRVO’s management and analyzing its recent drug trial results, Boral believes that the company can improve ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results